DE2122485A1 - Verfahren zur Herstellung von Aminen - Google Patents
Verfahren zur Herstellung von AminenInfo
- Publication number
- DE2122485A1 DE2122485A1 DE19712122485 DE2122485A DE2122485A1 DE 2122485 A1 DE2122485 A1 DE 2122485A1 DE 19712122485 DE19712122485 DE 19712122485 DE 2122485 A DE2122485 A DE 2122485A DE 2122485 A1 DE2122485 A1 DE 2122485A1
- Authority
- DE
- Germany
- Prior art keywords
- group
- hydrogen
- lower alkyl
- formula
- formyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH680670A CH543479A (de) | 1970-05-06 | 1970-05-06 | Verfahren zur Herstellung von Phenyläthylaminderivaten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2122485A1 true DE2122485A1 (de) | 1971-11-25 |
Family
ID=4315303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19712122485 Pending DE2122485A1 (de) | 1970-05-06 | 1971-05-06 | Verfahren zur Herstellung von Aminen |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3763218A (enExample) |
| AT (1) | AT311942B (enExample) |
| BE (1) | BE766734A (enExample) |
| CH (1) | CH543479A (enExample) |
| DE (1) | DE2122485A1 (enExample) |
| ES (1) | ES390895A1 (enExample) |
| FR (1) | FR2100634B1 (enExample) |
| GB (1) | GB1334430A (enExample) |
| HU (1) | HU163552B (enExample) |
| IE (1) | IE35186B1 (enExample) |
| IL (1) | IL36664A (enExample) |
| NL (1) | NL7106015A (enExample) |
| ZA (1) | ZA712326B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4037708A1 (de) * | 1989-11-28 | 1991-05-29 | Interneuron Pharma | Appetitzuegler und verfahren zu seiner anwendung |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE363276T1 (de) | 2000-10-30 | 2007-06-15 | Janssen Pharmaceutica Nv | Tripeptidylpeptidase-hemmer |
| US7041681B2 (en) * | 2002-04-29 | 2006-05-09 | Janssen Pharmaceutica N.V. | Compounds as opioid receptor modulators |
| US20050130243A1 (en) * | 2003-12-15 | 2005-06-16 | Zheng Yi F. | Assay for entactogens |
| US6991911B2 (en) * | 2003-12-15 | 2006-01-31 | Dade Behring Inc. | Assay for entactogens |
| US7022492B2 (en) * | 2003-12-15 | 2006-04-04 | Dade Behring Inc. | Ecstasy haptens and immunogens |
| US7037669B2 (en) * | 2004-03-22 | 2006-05-02 | Dade Behring Inc. | Assays for amphetamine and methamphetamine using stereospecific reagents |
| US7115383B2 (en) | 2004-03-22 | 2006-10-03 | Dade Behring Inc. | Assays for amphetamine and methamphetamine |
| EP1948713B1 (en) | 2005-10-12 | 2013-12-04 | Bezwada Biomedical LLC | Functionalized amino acids and absorbable polymers therefrom |
-
1970
- 1970-05-06 CH CH680670A patent/CH543479A/de not_active IP Right Cessation
-
1971
- 1971-04-13 ZA ZA712326A patent/ZA712326B/xx unknown
- 1971-04-20 IL IL36664A patent/IL36664A/xx unknown
- 1971-04-28 US US00139297A patent/US3763218A/en not_active Expired - Lifetime
- 1971-05-03 NL NL7106015A patent/NL7106015A/xx unknown
- 1971-05-03 IE IE553/71A patent/IE35186B1/xx unknown
- 1971-05-05 HU HUHO1375A patent/HU163552B/hu unknown
- 1971-05-05 ES ES390895A patent/ES390895A1/es not_active Expired
- 1971-05-05 BE BE766734A patent/BE766734A/xx unknown
- 1971-05-05 GB GB1322071*[A patent/GB1334430A/en not_active Expired
- 1971-05-05 AT AT391071A patent/AT311942B/de not_active IP Right Cessation
- 1971-05-05 FR FR7116194A patent/FR2100634B1/fr not_active Expired
- 1971-05-06 DE DE19712122485 patent/DE2122485A1/de active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4037708A1 (de) * | 1989-11-28 | 1991-05-29 | Interneuron Pharma | Appetitzuegler und verfahren zu seiner anwendung |
Also Published As
| Publication number | Publication date |
|---|---|
| IE35186B1 (en) | 1975-12-10 |
| GB1334430A (en) | 1973-10-17 |
| US3763218A (en) | 1973-10-02 |
| ES390895A1 (es) | 1973-07-01 |
| IL36664A (en) | 1974-07-31 |
| IE35186L (en) | 1971-11-06 |
| HU163552B (enExample) | 1973-09-27 |
| IL36664A0 (en) | 1971-06-23 |
| FR2100634A1 (enExample) | 1972-03-24 |
| AT311942B (de) | 1973-12-10 |
| NL7106015A (enExample) | 1971-11-09 |
| BE766734A (fr) | 1971-11-05 |
| FR2100634B1 (enExample) | 1975-06-06 |
| ZA712326B (en) | 1972-04-26 |
| CH543479A (de) | 1973-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2560549C2 (enExample) | ||
| EP0111873B1 (de) | Derivate der cis, endo-2-Azabicyclo-(5.3.0)-decan-3-carbonsäure, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung | |
| EP0258729A2 (de) | Dihydropyridinverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE2122485A1 (de) | Verfahren zur Herstellung von Aminen | |
| DE3223463A1 (de) | Substituierte 3-azabicyclo(3.1.0)hexane und verfahren zur behandlung von depressionen unter verwendung von substituierten 3-azabicyclo(3.1.0)hexanen | |
| EP0425906A2 (de) | Substituierte Cycloalkano[b]dihydroindol- und -indolsulfonamide | |
| DE2153799A1 (de) | Indolinderivate | |
| DE2306671A1 (de) | Neue pyridinverbindungen und verfahren zu ihrer herstellung | |
| DE2142526A1 (de) | Neue Benzopyranverbindungen und Verfahren zu deren Herstellung | |
| DE69104083T2 (de) | Neue Antiulcus-Substanz. | |
| CH542201A (de) | Verfahren zur Herstellung von Indolinderivaten | |
| DE3532279A1 (de) | 1,4-benzoxathiin-derivate | |
| EP0170861B1 (de) | 3-Aminocarbonylmethoxy-5-phenylpyrazol-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2337068A1 (de) | 1-benzylindenylsaeuren | |
| EP0065295A1 (de) | Substituierte Tryptaminderivate von Thienyloxypropanolaminen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen sowie ihre Verwendung | |
| DD142545A5 (de) | Verfahren zur herstellung neuer omega thiobutyramide | |
| DE60206376T2 (de) | Faktor xa inhibitor | |
| DE3102769A1 (de) | "bis-moranolinderivate" | |
| EP0171645A1 (de) | Neue 2H-1-Benzopyran-2-on-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten | |
| DE2039426C3 (de) | 1-Benzyliden-indenyl-(3)-essigsäuren, deren nicht-toxische, pharmakologisch verträgliche Salze, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| DE2412388A1 (de) | Dibenzothiophenderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel | |
| DE2025518A1 (enExample) | ||
| DE3423003A1 (de) | Benzo(c)(1,8)naphthyridine, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen | |
| DE2004301A1 (de) | Phenylserinderivate | |
| EP0088986A2 (de) | Bicyclische Phenolether, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHA | Expiration of time for request for examination |